• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

No Transfusion-Transmission of Classic Creutzfeldt-Jakob Disease

July 17, 2024

Classic Creutzfeldt-Jakob disease (CJD) is a rare and fatal neurodegenerative spongiform encephalopathy caused by prions (i.e., misfolded proteins). First recognized in the early 20th century, classic CJD can be categorized as sporadic (~85% of cases), genetic (10% to 15% of cases), or iatrogenic (<1% of cases). Variant CJD is a distinct form of the disease, sometimes called “mad cow disease,” that was linked to beef products in 1992, mainly in the United Kingdom (UK). Transfusion transmission of variant CJD has been documented in four cases all prior to 2004. Since 1995, the American Red Cross (ARC) and the U.S. Centers for Disease Control and Prevention (CDC) have investigated the potential for transfusion-transmission of classic CJD in the U.S. Between 1995 and 2023, the ARC identified 84 blood donors who later were diagnosed with classic CJD (96.4% sporadic, 2.4% genetic, and 1.2% iatrogenic). These donors gave 3,284 blood components of which 1,245 were possible to follow in transfusion recipients. Based on 6,495 person-years of observation, no cases of transfusion-transmission of classic CJD were identified. Likewise, no cases were identified in the UK and Scandinavia from comparable studies in over 8,800 transfusion recipients, totaling more than 15,500 person-years. Although transfusion-transmission of classic CJD remains theoretical, lookback studies strongly suggest that the risk is very low.

Reference:

Crowder LA, Dodd RY, Schonberger LB. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study. Transfusion. 2024 Jun;64(6):980-985

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Double-Unit Cord-Blood Transplants Are Not Advantageous Compared to Single-Unit Transplants

  • NIH Urges Randomized Controlled Trials for COVID-19 Convalescent Plasma

  • Leukoreduction Alone May Be Sufficient to Prevent Transfusion-Transmitted Cytomegalovirus Infection in Preterm Infants

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley